packageBlarcamesine

blarcamesine

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Blarcamesine is an investigational drug developed for dementia. It is not approved; a marketing application in the European Union was withdrawn, so it remains experimental.

Summary written by glm-5.3-flash from Wikidata Q25110485 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:blarcamesine
ATC codes:N06DX06
DrugBank:DB05592
PubChem CID:9882189
Wikidata:Q25110485
formula:C19H23NO
molar mass:281.399 g/mol (PubChem CID 9882189)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown